Jasper Therapeutics Target Price

Analysts' average 12-month price target for Jasper Therapeutics is $2.

Get informed when a big investor buys or sells

+ Follow

Share Price

$0.51

Average Target Price

$2.00

292.2% upside

1 analysts in the last 4 months

High: $2 | Low: $2

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-12	Piper SandlerBiren Amin	$2	292.2% upside
2026-05-15	RBC Capital	$3	488.2% upside
2025-01-09	RBC CapitalGregory Renza	$48	9311.8% upside
2024-12-05	BMO CapitalEtzer Darout	$63	12252.9% upside
2024-05-06	H.C. WainwrightEmily Bodnar	$65	12645.1% upside
2024-04-03	Evercore ISIGavin Clark-Gartner	$65	12645.1% upside
2023-02-07	Cantor Fitzgerald	$6	1076.5% upside
2023-01-11	Credit Suisse	$3	488.2% upside

Jasper Therapeutics (JSPR) FAQ

The latest target price for JSPR is $2. Investors often review this figure alongside Jasper Therapeutics's historical trend and sector peers before judging valuation or financial health.

Jasper Therapeutics trades near $0.51 while the consensus target sits at $2 (292.2% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting JSPR's target price ($2), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.